ExcepGen
ExcepGen is a biotechnology company focused on developing breakthrough biologics, gene therapies, and vaccines. They are dedicated to creating more effective biotherapeutics by addressing core biological challenges, particularly through their RNAx platform that dampens overactive innate immune responses to nucleic acid-based medicines. Their mission is to improve human health by exploring foundational principles of biology and challenging biological paradigms.
Industries
Nr. of Employees
small (1-50)
Products
Platform for mRNA-encoded immunomodulatory proteins
A platform that uses mRNA to express proteins which modulate cellular innate immune responses to nucleic acids and LNPs, intended to improve tolerability of RNA medicines.
Platform for mRNA-encoded immunomodulatory proteins
A platform that uses mRNA to express proteins which modulate cellular innate immune responses to nucleic acids and LNPs, intended to improve tolerability of RNA medicines.
Services
R&D collaboration for mRNA therapeutics and vaccines
Collaborative research and development partnerships to apply platform technologies for mRNA-based vaccines, biologics, and gene therapies.
R&D collaboration for mRNA therapeutics and vaccines
Collaborative research and development partnerships to apply platform technologies for mRNA-based vaccines, biologics, and gene therapies.
Expertise Areas
- mRNA therapeutics
- Vaccine platform development
- Innate immune modulation
- Synthetic biology
Key Technologies
- Self-amplifying mRNA
- Trans-amplifying mRNA
- mRNA-encoded protein expression
- Lipid nanoparticle interactions